USFDA inspection at Zydus Lifesciences Ahmedabad unit ends with one observation
In short
Zydus Lifesciences said a USFDA inspection of its Ahmedabad factory ran from September 21 to 28 and ended with one observation.
The company says it will deal with the issue. The report does not say what the observation was or whether it will affect the business.
What the reporting says
A USFDA inspection at Zydus Lifesciences’ Ahmedabad manufacturing facility ran from September 21 to 28 and ended with one observation. The company said it will address the observation, according to the publisher summary. The reporting does not state what the observation was, whether it is critical, or whether it will affect production, approvals, or sales.
Why it matters
The USFDA inspection at Zydus Lifesciences’ Ahmedabad facility covered September 21 to 28 and ended with one observation, according to the publisher summary. Zydus said it will address the observation. The report does not explain the issue, its severity, or any effect on approvals, manufacturing, or revenue.